ALDX FY 2016 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ALDXAldeyra Therapeutics, Inc.

$290M

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$35,792

Operating Income

-$19M

Net Income

-$19M

EPS (Diluted)

$-1.65

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$25M

Total Liabilities

$4M

Stockholders' Equity

$22M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$35,792	-$18,778	-90.6%
Operating Income	-$19M	-$12M	-55.9%
Net Income	-$19M	-$12M	-54.7%